The role of Vitamin C and D in Ovarian Cancer

Ovarian cancer is the eleventh most prevalent kind of cancer and the most aggressive of all reproductive malignancies and is the fifth leading cause of cancer-related mortality in women. Ovarian cancer is a poor prognosis cancer with a late-stage appearance. Women frequently exhibit "silent symptoms," such as pain in the abdominal pain (AP), delaying referral for a malignancy checkup. The incidence of ovarian cancer is supposedly inversely correlated with the lifetime amount of ovulation, according to the risk factors such as early menarche, nulliparity, and late menopause, as well as the preventive factors of higher parity, usage of oral contraceptives, and longer lactation. The poor prognosis for this illness justifies research to find risk variables that might be changed to lower risk. Diet and vitamin supplements continue to be one of the primary lifestyle variables known to affect cancer risk, while specific correlations with this cancer risk are less clear. Overall, a relationship between some vitamins and ovarian cancer is biologically plausible. To summarize the existing research, in this narrative review of the Association between vitamin C and D in ovarian cancer. According to our findings, there is a strong case for the potential use of vitamin C and D as a supplement in ovarian cancer patients due to the low cost, the few side effects, a noticeable increase in the quality of life, and potential anti-cancer effectiveness